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Abstract 
Objectives: The prevalence of liver cirrhosis is increasing, and many patients have acute conditions requiring consid-
eration of intensive care. This study aims to: (a) report the outcome at 12 months of patients with cirrhosis admitted 
to ICU, (b) identify factors predictive of long-term mortality and (c) evaluate the ability of scoring systems to predict 
long-term outcome.
Design: Observational cohort study.
Setting: General adult critical care unit in a UK teaching hospital.
Patients: Eighty-four patients admitted to critical care between June 2012 and December 2013.
Primary outcome measures: Cumulative survival at ICU discharge, hospital discharge and 12 months.
Results: Eighty-four patients with diagnosed cirrhosis were followed up at 12 months. Clinical variables collected 
at ICU admission were entered into a multivariate regression analysis for mortality and eight predetermined scoring 
systems calculated. Cumulative survival at ICU discharge, hospital discharge and 12 months was 64.8, 47.1 and 44.1%, 
respectively. Twelve months of cumulative survival in patients with Child–Pugh class A was 100%, class B was 50% 
and class C was 25% (log rank p = 0.002). Independent predictors of mortality at 12 months were lactate, bilirubin, 
PT ratio and age. The Child–Pugh + Lactate score was modified to produce an objective score comprising Albumin, 
Bilirubin and Clotting (PT ratio) added to serum lactate concentration in mmol L−1 (ABC + Lactate). This score was the 
best predictor of 12-month survival, with an AUC of 0.83. A proposed classification by ABC + Lactate score was highly 
significant (p = 0.001), with those in the highest class having ICU mortality of 75% and hospital and 12-month mortal-
ity of 93%.
Conclusions: Patients with cirrhosis admitted to ICU have high initial mortality but low mortality after hospital 
discharge. Child–Pugh class at ICU admission predicts outcome at 12 months. The ABC + Lactate classification system 
may be useful in identifying critically ill cirrhotic patients with very high long-term mortality.
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Background
Liver disease is the third most common cause of prema-
ture death in the United Kingdom (UK) [1], and patients 
with liver cirrhosis now comprise between 2.6 and 15% of 
admissions to intensive care units (ICUs) in the UK [2–
5]. Though survival in this patient group has historically 
been very poor, with reported hospital mortality as high 
as 89% [6–8], it has recently demonstrated that short-
term survival is now improving [9–11].
Whilst this population has been well-studied with 
respect to short-term outcome [3–5, 10–14], relatively few 
studies have reported on long-term outcomes of critically 
ill cirrhotic patients. A 2006 study from a Scottish trans-
plant centre demonstrated 12-month mortality of 81% in 
ICU admissions with decompensated alcoholic cirrho-
sis [4]; other non-UK transplant centres have reported 
6-month mortality of between 62 and 71% [15–17]. Long-
term outcome data from cirrhotic patients admitted to 
general ICUs are also scarce, with one European centre 
reporting 6-month mortality of 60% amongst all admis-
sions, another reporting 12-month mortality of 82% and 
one UK centre reporting 12-month mortality of 59% [3, 18, 
19].
It is difficult to predict which patients will benefit from 
ICU admission, and the use of scoring systems has been 
proposed to inform clinical decision-making. The most 
widely used method for assessing patients with chronic 
liver disease is the Child–Pugh score; however, this has 
been found to poorly predict short-term outcome in cir-
rhotic patients admitted to ICU [5, 11, 12, 19–21]. Many 
studies have found general critical illness scores, such as 
Acute Physiology, Age and Chronic Health Evaluation 
II (APACHE II) and Sequential Organ Failure Assess-
ment (SOFA) to be superior to liver-specific scores such 
as Child–Pugh, the Model for End-Stage Liver Disease 
(MELD) and the UK Model for End-Stage Liver Dis-
ease (UKELD) [5, 11, 15, 18, 21]. Novel scores have also 
been designed for the acutely ill cirrhotic population, 
such as the Royal Free Hospital (RFH) score [11] and the 
Chronic Liver Failure-Sequential Organ Failure Assess-
ment (CLIF-SOFA) [22]. Increased serum lactate has 
been widely found to predict short-term mortality in 
critically ill cirrhotic patients [5, 11, 12, 16, 23], leading 
to the development of scores incorporating lactate such 
as SOFA-Lactate [16]. Child–Pugh  +  Lactate was also 
found to be the best performing score at predicting ICU 
mortality in a previous study from this centre [5].
Despite this significant body of research, none of these 
scores have been validated with respect to long-term out-
comes of critically ill cirrhotic patients. The aims of our 
study were: (a) to report the 12-month outcome of cir-
rhotic patients admitted to a general ICU; (b) to identify 
any factors predictive of survival at 12 months; and (c) to 
compare the ability of scoring systems to predict long-
term outcome in this population.
Methods
An observational cohort study of patients with liver cir-
rhosis admitted to the adult ICU at Glasgow Royal Infir-
mary was undertaken between June 2012 and December 
2013. We have previously reported on the acute mortal-
ity of this population [24]. This unit is a 20-bed mixed 
surgical and medical critical care unit within a univer-
sity hospital which does not provide liver transplant ser-
vices. Patients were enrolled if they had received ‘Level 3’ 
care in the unit, defined as multiple organ support and/
or mechanical ventilation. A diagnosis of cirrhosis was 
made if the patient had a positive liver biopsy on record, 
or if they had clinical features of cirrhosis plus any of 
the following: evidence of portal hypertension, ascites, 
encephalopathy or signs of liver cirrhosis on ultrasound 
examination. Patients with all aetiologies of liver cirrho-
sis were included, and all diagnoses were validated by a 
second independent clinician. Patients who were consid-
ered eligible for acute liver transplantation were referred 
to the regional transplant centre.
Data were collected prospectively from the Philips 
Intellivue Clinical Information Portfolio (Philips Medical 
Systems, Eindhoven, the Netherlands) and WardWatcher 
(Critical Care Audit Ltd., Yorkshire, UK) computerised 
patient record systems at the time of ICU admission. 
Demographic data collected included: age, gender, post-
code, indication for ICU admission and aetiology of cir-
rhosis. The postcode was used to calculate the Scottish 
Index of Multiple Deprivation (SIMD) quintile for each 
patient, with those in the lowest quintile considered 
socially deprived. Clinical data were taken from the first 
recorded value following the documented time of ICU 
admission and included sodium, potassium, urea, arte-
rial lactate, bilirubin, albumin, creatinine, total white cell 
count, prothrombin time (PT) ratio, platelet count, ratio 
of arterial oxygen partial pressure to fraction of inspired 
oxygen  (PaO2/FiO2 ratio), and ascites and encephalopa-
thy grades. Encephalopathy was graded using the West 
Haven criteria prior to intubation or sedation.
Based on the previously described literature, several 
scoring systems were chosen for inclusion in this study 
and were calculated at admission as previously described 
by their authors. These comprised Child–Pugh [25], 
MELD, UKELD, APACHE II and SOFA [25–29]. In addi-
tion to these established systems, the novel RFH, CLIF-
SOFA, SOFA-Lactate and Child–Pugh  +  Lactate were 
calculated [5, 11, 16, 22]. The Child–Pugh class was 
assigned retrospectively based on the score at admission.
Patient outcome data were obtained via electronic patient 
record systems which are linked to death notification 
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records and by contacting patients’ primary care physicians 
to confirm survival if in doubt. Outcomes of interest were 
survival to ICU discharge, survival to hospital discharge 
and survival at 12 months post-hospital discharge. Ethical 
approval was granted by the West of Scotland Research 
Ethics Committee (REC reference; 12/WS/0039).
Statistical analysis
Parametric data were reported as mean and standard 
deviation and compared using Student’s t test. Nonpar-
ametric data were reported as median and interquartile 
range and compared using the Mann–Whitney U test. 
Proportions were compared using the Fisher’s exact test 
or Chi-squared test for association or trend, as appropri-
ate. All p values calculated were two-sided, and the statis-
tical significance threshold was <0.05.
All parameters which were under the significance 
threshold of <0.05 were entered into a stepwise, back-
ward multivariate logistic regression analysis for mortal-
ity at 12 months. Receiver operating characteristic (ROC) 
curves were calculated for each scoring system, and the 
area under the curve (AUC) was determined. A thresh-
old of AUC ≥ 0.8 for clinical utility was chosen in keep-
ing with previous studies on this topic and statistical 
literature [30]. Survival analysis was conducted using the 
Kaplan–Meier method, from which readmissions were 
excluded in order to not confound the analysis. In such 
cases, the patient’s initial ICU admission date was used in 
the Kaplan–Meier analysis. Where subgroups were ana-
lysed separately, the log-rank test was used to compare 
the survival curves, with correction for trend if appro-
priate. All statistical analysis was performed using SPSS 
version 21 (SPSS, Inc., IBM, Chicago, USA). Advice was 
sought from an independent statistician.
Results
Demographics
Of 611 admissions screened during the study period, 84 
met the diagnostic criteria for cirrhosis. Two of these 
admissions had missing data for a small number of vari-
ables. This meant that certain parameters, including 
some scoring systems, could not be calculated; however, 
they were included for all other analyses. The character-
istics of the cohort are listed in Table 1. The mean patient 
age was 50.2 ± 11.2 years. Fifty-nine admissions (70.2%) 
were male. Fifty-six (66.7%) were from a socially deprived 
background. In 70 admissions (83.3%), the patient had 
alcohol-related disease. In 58 admissions (69.0%), the 
patient was receiving mechanical ventilation on arrival 
in the ICU. Sixty-eight (81.0%) were first admissions, and 
16 (19.0%) were ICU readmissions during the same hos-
pital stay. None of the patients admitted during the study 
period had been previously admitted to ICU in a separate 
hospital episode. The median ICU stay was 5 days (IQR 
1–12.8).
The most common working diagnosis at ICU admission 
was pneumonia (n = 19, 22.6%) followed by gastrointes-
tinal bleeding (n = 11, 13.1%), acute respiratory distress 
syndrome (ARDS) (n = 8, 9.5%), and systemic sepsis (n = 
7, 8.3%), encephalopathy, gastrointestinal perforation and 
trauma, including burns (all n = 5, 6.0%), and decompen-
sated cirrhosis and seizures (both n = 4, 4.8%).
Long‑term outcome and survival analysis
Long-term outcome data were available for all 84 admis-
sions. After exclusion of readmissions, 68 patients were 
entered into the Kaplan–Meier analysis. The cumulative 
mortality at 12  months after ICU admission was 55.9%, 
with 38 deaths occurring. ICU mortality was 24 patients 
(35.2%), and a further 12 patients (17.6%) died in hospi-
tal after leaving ICU, giving a hospital mortality of 52.9%. 
Only 2 patients (2.9%) died in the community follow-
ing hospital discharge. A summary figure is provided in 
Fig. 1, and the Kaplan–Meier curve for the whole cohort 
is given in Fig.  2. Subgroup analysis stratifying by the 
presence of alcohol-related disease or social deprivation 
showed no significant difference between survival curves 
(p = 0.634 and p = 0.537 respectively).
Factors predictive of long‑term mortality
Factors found to be predictive of mortality at 12  months 
in univariate analysis were increased age (p = 0.020), arte-
rial lactate, serum bilirubin concentration, and PT ratio 
(all p  <  0.001), serum albumin (p  =  0.002), creatinine 
(p  =  0.029) and platelet count (p  =  0.005). Readmission 
during the same hospital stay was associated with increased 
long-term survival (p  =  0.008). There was no significant 
effect observed of the presence of alcohol-related disease or 
levels of social deprivation on long-term survival, or any of 
the other clinical measurements (Table 1).
Readmission during hospital stay was excluded from the 
multivariate analysis as this is a subjective clinical deci-
sion highly likely to be affected by external factors. After 
multivariate analysis, only four variables remained sta-
tistically significant for mortality at 12  months: age (OR 
1.09, 95% CI 1.03–1.15, p = 0.002), serum arterial lactate 
(OR 1.57, 95% CI 1.12–2.20, p  =  0.010), serum biliru-
bin (OR 1.01, 95% CI 1.00–1.02, p = 0.015) and PT ratio 
(OR 4.82, 95% CI 1.38–16.82, p  =  0.014). These details 
are given in Table 2. Based on these findings, the Child–
Pugh + Lactate score was adapted to focus on the most 
significant components of the regression model. This was 
done by removing the ascites and encephalopathy compo-
nents, leaving a system with a combined point score based 
on albumin, bilirubin and PT ratio added to the serum 
arterial lactate concentration. This novel score, referred to 
Page 4 of 9Warren et al. Ann. Intensive Care  (2017) 7:37 
from now on as the ABC + Lactate, for Albumin, Biliru-
bin and Clotting (PT ratio), is shown in Table 3.
Discriminative ability of scoring systems
All scoring systems studied were predictive of mortal-
ity at 12  months (p  <  0.001 for all except Child–Pugh, 
p  =  0.001). ROC curves were calculated for all scoring 
systems for prediction of 12-month survival, and the area 
under the curve values (AUC) are given in Table 4. Based 
on 95% confidence intervals, there were no statistically 
significant differences between any of the scoring systems 
evaluated. The only two existing systems which produced 
Table 1 Clinical characteristics and predictors of 12-month mortality in 84 admissions to a general ICU with a diagnosis 
of cirrhosis
All data are given as median (interquartile range) unless stated otherwise
SIMD Scottish Index of Multiple Deprivation, GI gastrointestinal, ARDS acute respiratory distress syndrome, PT prothrombin time, 12 m 12 months
* Statistically significant characteristics (p < 0.05)
a Social deprivation was defined as SIMD quintile 1 (lowest)
b Other include: urinary tract infection, renal failure, respiratory failure (not secondary to infection and does not meet criteria for ARDS), acute cholecystitis, biliary 
obstruction, diabetic ketoacidosis and post-cardiac arrest
All admissions (n = 84) 12 m survivors (n = 43) 12 m nonsurvivors (n = 41) p value
Age (mean ± SD, range)* 50.2 ± 11.2 47.4 ± 10.1 53.1 ± 11.8 0.020
Male gender (n) 59 (70.2%) 32 (74.4%) 27 (65.9%) 0.391
SIMD quintile 1 (1–2) 1 (1–2) 1 (1–2) 0.755
Social  deprivationa (n) 56 (66.7%) 31 (72.1%) 25 (61.0%) 0.356
Alcohol-related disease (n) 70 (83.3%) 36 (83.7%) 34 (82.9%) 0.922
Ventilated on admission (n) 58 (69.0%) 30 (69.8%) 28 (68.3%) 0.884
Readmission during same hospital stay* 16 (19.0%) 13 (30.2%) 3 (7.3%) 0.008
ICU admission reason 0.114
 Pneumonia 19 (22.6%) 12 (27.9%) 7 (17.1%)
 GI haemorrhage 11 (13.1%) 6 (14.0%) 5 (12.2%)
 ARDS 8 (9.5%) 4 (9.3%) 4 (9.8%)
 Sepsis 7 (8.3%) 2 (4.7%) 5 (12.2%)
 Encephalopathy 5 (6.0%) 3 (7.0%) 2 (4.9%)
 GI perforation 5 (6.0%) 0 (0.0%) 5 (12.2%)
 Trauma/burns 5 (6.0%) 3 (7.0%) 2 (4.9%)
 Decompensated cirrhosis 4 (4.8%) 0 (0.0%) 4 (9.8%)
 Seizures 4 (4.8%) 3 (7.0%) 1 (2.4%)
 Otherb 10 (11.9%) 5 (6%) 5 (6%)
 Drug related 4 (4.8%) 4 (4.8%) 0 (0%)
 Pancreatitis 2 (2.4%) 1 (1.2%) 1 (1.2%)
Length of ICU stay 5 (1–12.8) 7 (2–13) 5 (1–12.5) 0.243
Sodium (mEq L−1) 136.0 (132.0–140.8) 138.0 (135.0–142.0) 133 (131–140) 0.066
Potassium (mEq L−1) 3.9 (3.6–4.5) 3.9 (3.6–4.3) 3.9 (3.5–4.8) 0.809
Urea (mmol L−1) 8.1 (4.1–12.8) 7.1 (4.1–11.6) 9.2 (4.9–14.7) 0.123
Lactate* (mmol L−1) 1.9 (1.3–2.9) 1.5 (1.1–2.1) 2.4 (1.7–5.4) <0.001
Bilirubin* (µmol L−1) 45.5 (20.8–108.3) 28 (14–70) 71 (41–198) <0.001
Creatinine* (µmol L−1) 81.5 (57.3–162.3) 71 (57–114) 131 (63.5–197) 0.029
White cell count (×10−9 L−1) 12.4 (7.9–17) 13.3 (8.4–17.4) 7.45 (10.6–18.6) 0.466
Albumin* (g L−1) 20 (17–26) 23 (19–28) 18 (15.5–22) 0.002
PT ratio* 1.5 (1.2–2.0) 1.4 (1.1–1.7) 1.7 (1.5–2.5) <0.001
Platelet count* (×10−9 L−1) 109.5 (81.5–180.8) 133 (88–215) 94 (59.5–144) 0.005
PaO2/FiO2 ratio (kPa) 21.7 (12.4–36.1) 28.3 (14.5–38.9) 18.2 (11.8–32.6) 0.070
Glasgow coma score 10.5 (3–15) 10 (5–14) 11 (3–15) 0.873
Ascites (n) 35 (41.7%) 14 (32.6%) 21 (51.2%) 0.083
Encephalopathy (n) 29 (34.5%) 13 (30.2%) 16 (39.0%) 0.397
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AUCs over the predetermined cut-off for clinical utility 
were MELD (AUC = 0.82, 95% CI 0.74–0.91) and Child–
Pugh + Lactate (0.80, 95% CI 0.71–0.90). The proposed 
ABC + Lactate score gave the highest AUC, with a value 
of 0.83 (95% CI 0.74–0.92).
Comparison of classification systems
At the time of ICU admission, 6 patients (8.8%) had 
Child–Pugh class A disease, 34 (50.0%) had class B, and 
28 (41.2%) had class C. Subgroup survival analysis by 
Child–Pugh class at ICU admission showed significant 
Fig. 1 Summary of 18-month observational cohort study of patients with cirrhosis admitted to a general ICU
Fig. 2 Kaplan–Meier survival curve of 68 patients with cirrhosis 
admitted to a general ICU
Table 2 Factors predictive of mortality at 12 months post-
ICU admission after  a backwards stepwise multivariate 
logistic regression analysis
PT prothrombin time
a PT ratio odds ratio is based on increments of 1
Odds ratio 95% confidence interval p value
Age (years) 1.09 1.03, 1.15 0.002
Lactate (mmol L−1) 1.57 1.12, 2.20 0.010
PT  ratioa 4.82 1.38, 16.82 0.014
Bilirubin (µmol L−1) 1.01 1.00, 1.02 0.015
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differences between the Kaplan–Meier curves (p = 0.002, 
Fig.  3): cumulative mortality at 12  months was 0.0% in 
patients presenting with Child–Pugh class A, 50.0% in 
patients with class B, and 75.0% in class C. Following its 
superior performance in ROC curve analysis, a classifica-
tion system was also produced based on the ABC + Lac-
tate score (Table 3), using empirical analysis of the ROC 
curve (not shown) to find integer cut-off points which 
would provide either good sensitivity or specificity. Those 
with an ABC + Lactate less than 8 were considered class 
1 (n = 27, 40.9%), those scoring between 8 and 10.9 class 
2 (n = 23, 34.8%), and those scoring 11 or higher class 3 
(n = 15, 22.4%). Kaplan–Meier analysis by ABC + Lac-
tate class at admission was highly significant (p = 0.001, 
Fig.  4). Cumulative mortality at 12  months was 25.9% 
for ABC + Lactate grade 1, 66.7% for grade 2 and 93.3% 
for grade 3. A comparison of Child–Pugh class and 
ABC + Lactate class for all three timepoints is given in 
Table 5.
Discussion
Our findings show that cirrhotic patients admitted to 
ICU have high initial mortality followed by a low mor-
tality in those patients who survive to leave hospital. 
In comparison with other reports of cirrhotic patients 
from general ICUs, our 12-month cumulative mortality 
of 55.9% is comparable to the figure of 59% reported by 
Lewis et al. and the 6-month cumulative mortality of 60% 
reported by Filloux et al. [3, 18] It is, however, far lower 
Table 3 Proposed ABC  +  Lactate score for  prediction 
of outcome in cirrhotic patients admitted to ICU
Lactate (mmol L−1) added to the total points score from above
Classification: ABC + Lactate <8 = Class 1, 8–10.9 = Class 2, ≥11 = Class 3
1 point 2 points 3 points
Albumin  (gL−1) >35 28–35 <28
Bilirubin (µmolL−1) <35 35–50 >50
Clotting (PT ratio) <1.7 1.7–2.3 >2.3
Table 4 Utility of  scoring systems at  predicting 12-month 
outcome in patients with cirrhosis admitted to ICU
APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ 
Failure Assessment, CLIF-SOFA Chronic Liver Failure-SOFA, MELD Model for End-
Stage Liver Disease, UKELD UK Model for End-stage Liver Disease, RFH Royal Free 
Hospital score, ABC albumin, bilirubin and clotting
a Models with an area under curve above the threshold of 0.8
Area under ROC curve 95% confidence 
interval
APACHE II 0.763 0.662, 0.864
SOFA 0.748 0.642, 0.855
CLIF-SOFA 0.782 0.684, 0.880
SOFA-Lactate 0.769 0.667, 0.871
Child–Pugh 0.718 0.609, 0.828
MELDa 0.823 0.735, 0.911
UKELD 0.778 0.675, 0.882
RFH 0.779 0.679, 0.879
Child–Pugh + Lactatea 0.804 0.712, 0.896
ABC + Lactatea 0.831 0.744, 0.919
Fig. 3 Kaplan–Meier survival curve stratified by Child–Pugh class 
at ICU admission. Black lines Child–Pugh class A (n = 6). Green lines 
Child–Pugh class B (n = 34). Red lines Child–Pugh class C (n = 28). 
Log-rank p value = 0.002
Fig. 4 Kaplan–Meier survival curve stratified by ABC + Lactate class 
at ICU admission. Black lines ABC + Lactate class 1 (n = 27). Green lines 
ABC + Lactate class 2 (n = 24). Red lines ABC + Lactate class 3 (n = 
15). Log-rank p value = 0.001
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than the 90-day mortality of 76% reported by Kavli et al. 
[19] though this may be explained by the fact that the lat-
ter study only enrolled patients with decompensated cir-
rhosis and the fact that the majority of our cohort were 
admitted with alcohol-related cirrhosis. Compared to the 
contemporary literature from specialist liver ICUs, the 
outcome of the population of cirrhotic patients admitted 
to general ICUs appears to be slightly better than those 
requiring treatment in a specialist centre [15, 16]. As with 
our findings, all of these studies demonstrated a similar 
reduction in mortality after hospital discharge strongly 
suggesting that those cirrhotic patients who survive hos-
pital have good long-term outcomes [3, 15, 16, 19].
The independent predictors of mortality in this 
study were serum lactate, bilirubin, PT ratio and age. 
Increased lactate and bilirubin have both been widely 
found to predict short-term mortality in critically ill cir-
rhotic patients [5, 11, 12, 14, 16, 21, 23], but this is the 
first time they have been associated with poor long-
term outcome. Whilst the odds ratio of 4.82 for PT ratio 
appears large, this ratio represents the increased risk of 
mortality associated with an increase in the PT ratio of 
1, a significant clinical deterioration. Surprisingly, neither 
alcohol-related disease nor the presence of social depri-
vation was found to be associated with poorer outcome, 
although we may have underestimated a true population 
effect as the vast majority of the cohort had one or both 
of these risk factors. In contrast to a number of previ-
ous studies [2, 14, 15, 18], mechanical ventilation at ICU 
admission was not found to be associated with increased 
mortality. Notably, readmission to ICU was a significant 
predictor of survival, although this may reflect a bias 
where patients who were readmitted to ICU were those 
with the highest chance of survival.
We were unable to demonstrate a statistically sig-
nificant difference between the scoring systems based 
on ROC curve analysis; however, MELD, Child–
Pugh + Lactate and ABC + Lacate all achieved an AUC 
higher than the predetermined threshold. However, ROC 
curve analysis alone is unlikely to provide a true measure 
of a score’s clinical usefulness [24, 31]. A classification 
system with mortality rates for each class is far easier for 
clinicians to interpret and apply at the bedside, which a 
score alone does not permit.
A key finding of this study is that Child–Pugh class 
at ICU admission stratifies patients into three groups 
with different long-term prognosis (Fig.  3). However, 
the inherent limitations of this score must be realised 
when interpreting this finding. Our data demonstrate 
that patients presenting to ICU with Child–Pugh class 
A disease have excellent long-term outcome, but such 
patients form a small proportion of critically ill cirrhotic 
patients—data from this study and others indicate that 
the vast majority of cirrhotic patients who present to ICU 
are Child–Pugh class B or C [11, 12, 18]. Child–Pugh 
class alone is unable to identify which of these class B or 
C patients have a sufficiently high probability of short- 
and long-term death to influence a decision regard-
ing ICU admission. This limitation of Child–Pugh has 
been previously identified by a number of authors and 
may be due to a ‘ceiling’ effect of its classification sys-
tem [31]. It is therefore clear that there remains a need 
for a bedside scoring system with the ability to identify 
patients with the highest risk of mortality. Whilst MELD 
did perform well on this cohort, it is limited by the lack 
of an easily accessible grading system to stratify patient 
into groups and hence identify patients with a high risk 
of mortality. Similarly, the RFH score, which has been 
validated for short-term outcome in both the specialist 
and general settings [11, 24], failed to perform as well in 
this long-term study. The Child–Pugh  +  Lactate score 
attempted to meet this need with the incorporation of 
Table 5 Comparison of  cumulative survival by  Child–Pugh class and  CLIF-SOFA organ failure grade in  68 cirrhotic 
patients admitted to a general ICU
As readmissions were excluded so as not to confound the survival analysis, only 68 admissions are included
ABC albumin, bilirubin and clotting (PT ratio)
a 2 patients had insufficient data to calculate ABC + L
Child–Pugh A (n = 6) Child–Pugh B (n = 34) Child–Pugh C (n = 28) p value
Alive at ICU discharge 6 (100.0%) 24 (70.6%) 14 (50.0%) 0.015
Alive at hospital discharge 6 (100.0%) 18 (52.9%) 8 (28.6%) 0.002
Alive 12 m post-admission 6 (100.0%) 17 (50.0%) 7 (25.0%) 0.001
ABC + Lactate1 (n = 27)a ABC + Lactate 2 (n = 24)a ABC + Lactate 3 (n = 15)a p value
Alive at ICU discharge 24 (88.9%) 15 (62.5%) 3 (20.0%) <0.001
Alive at hospital discharge 20 (74.1%) 10 (41.7%) 1 (6.7%) <0.001
Alive 12 m post-admission 20 (74.1%) 8 (33.3%) 1 (6.7%) <0.001
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a measure of acute illness correlated with poor short-
term outcome [5]. However, this score remains limited 
as both the ascites and encephalopathy components are 
subjective and difficult to assess in the acute setting [24, 
31]. Previous work from this centre has demonstrated 
that the omission of encephalopathy scores from both 
Child–Pugh and Child–Pugh  +  Lactate did not affect 
the short-term predictive value [24], and so it is per-
haps unsurprising that the ABC + Lactate score, which 
removes these components, performed better in this 
study.
Unlike Child–Pugh, MELD, RFH and Child–
Pugh  +  Lactate, the ABC  +  Lactate score is entirely 
objective and can be calculated easily at the bedside; 
its similarity to the well-known Child–Pugh score may 
also promote easy understanding amongst clinicians. 
In this study, ABC  +  Lactate classification identified a 
large group of patients with good long-term prognosis, 
and a smaller but sizeable group of patients with almost 
universally poor outcome (Fig.  4). ABC +  Lactate class 
1 patients formed 41% of the cohort and had short- and 
long-term outcomes similar to the general ICU popula-
tion [32], whereas class 3 patients (22% of the cohort) 
had an ICU mortality of 75% and hospital and 12-month 
mortality of 93%. Crucially, ABC +  Lactate was able to 
identify a group of patients with very high long-term 
mortality (class 3), suggesting it may be useful as an 
adjunct to the Child–Pugh classification system to iden-
tify patients at very high risk of death in the critically ill 
cirrhotic population.
There were some limitations to this study. The sample 
size is sufficiently small that an overestimation of effect 
bias may have occurred, particularly with some of the 
subgroup analyses. It should also be noted that this is a 
single-centre study of all-cause general ICU admissions 
with cirrhosis, and therefore the conclusions may not be 
directly applicable to other populations of critically ill cir-
rhotic patients. The ABC + Lactate score would require 
validation for both short- and long-term outcome in an 
external cohort of patients before it could be adopted 
for use in this patient population. There were no data 
on the number of cirrhotic patients who were referred 
to ICU with a very poor prognosis and therefore not 
accepted for admission, or those cirrhotic patients who 
were critically ill but were not referred for critical care. 
Although in our centre the vast majority of such patients 
are indeed admitted to ICU, this may have led the study 
to underestimate the mortality of critically ill cirrhotic 
patients by excluding those who died prior to ICU admis-
sion. Similarly, we did not formally assess decompensa-
tion on admission and therefore cannot state surely the 
proportion of patients who were presenting with decom-
pensated liver disease. Finally, whilst we have assessed 
long-term mortality in hospital survivors as a binary out-
come, we have not been able to similarly assess ongoing 
morbidity. It is likely that many of these patients will have 
significant reductions in quality of life, which whilst an 
important endpoint was outside the scope of this study.
Conclusions
Patients with cirrhosis who become critically unwell 
should be considered for ICU admission, as whilst they 
have high initial mortality, those who leave hospital alive 
have good long-term outcomes. Child–Pugh class at ICU 
admission predicts outcome at 12  months but struggles 
to identify those patients at a very high risk of death. The 
novel ABC +  Lactate classification system may be use-
ful in identifying critically ill cirrhotic patients with very 
high long-term mortality.
Authors’ contributions
AW collected follow-up data, performed data analysis and wrote the manu-
script. Data collection was also performed by CS, JC, AP, TQ and JM. Expert 
statistical guidance was given by MS. CS and JM provided overall supervision 
of the study and assisted with revising the manuscript. JK contributed to the 
manuscript and provided expert guidance in the field of intensive care. All 
authors read and approved the final manuscript.
Author details
1 Academic Unit of Anaesthesia, Pain and Critical Care, University of Glasgow, 
Room 2.73, Level 2, New Lister Building, Glasgow Royal Infirmary, 10-16 
Alexandra Parade, Glasgow, Scotland G31 2ER, UK. 2 Intensive Care Unit, NHS 
Greater Glasgow and Clyde, 84 Castle Street, Glasgow, Scotland G4 OSF, UK. 
3 Medical Physics, NHS Greater Glasgow and Clyde, Level 2, New Lister Build-
ing, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow, Scotland G31 
2ER, UK. 
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
Unfortunately, we do not have permissions to share this data. However, if indi-
vidual research groups would like to access our raw data, we would be happy 
to collaborate with individual requests for this. Please contact the correspond-
ing author for further information.
Ethics approval
Ethical approval was granted by the West of Scotland Research Ethics Com-
mittee (REC reference; 12/WS/0039).
Funding
This research received no specific grant from any funding agency in the pub-
lic, commercial or not-for-profit sectors.
Received: 12 September 2016   Accepted: 8 March 2017
References
 1. Williams R, Aspinall R, Bellis M, et al. Addressing liver disease in the UK: a 
blueprint for attaining excellence in health care and reducing premature 
mortality from lifestyle issues of excess consumption of alcohol, obesity, 
and viral hepatitis. Lancet. 2014;384:1953–97.
 2. O’Brien AJ, Welch CA, Singer M, Harrison DA. Prevalence and outcome 
of cirrhosis patients admitted to UK intensive care: a comparison against 
dialysis-dependent chronic renal failure patients. Intensive Care Med. 
2012;38:991–1000.
Page 9 of 9Warren et al. Ann. Intensive Care  (2017) 7:37 
 3. Lewis H, Reynolds T, Lillis A, Maitland K, Foster GR, Hadley J. Mortality 
and utility of prognostic scoring models in cirrhotic patients admit-
ted to a tertiary non-transplant intensive care unit (ICU) in the UK. Gut. 
2012;61(Suppl 2):A199.
 4. Mackle IJ, Swann DG, Cook B. One year outcome of intensive care 
patients with decompensated alcoholic liver disease. Br J Anaesth. 
2006;97:496–8.
 5. Emerson P, McPeake J, O’Neill A, et al. The utility of scoring systems in 
critically ill cirrhotic patients admitted to a general intensive care unit. J 
Crit Care. 2014;29(6):1131.e1–6.
 6. Goldfarb G, Nouel O, Poynard T, Rueff B. Efficiency of respiratory 
assistance in cirrhotic patients with liver failure. Intensive Care Med. 
1983;9:271–3.
 7. Shellman RG, Fulkerson WJ, DeLong E, Piantadosi CA. Prognosis of 
patients with cirrhosis and chronic liver disease admitted to the medical 
intensive care unit. Crit Care Med. 1988;16:671–8.
 8. Kress JP, Rubin A, Pohlman AS, Hall JB. Outcomes of critically ill patients 
denied consideration for liver transplantation. Am J Respir Crit Care Med. 
2000;162:418–23.
 9. Galbois A, Trompette ML, Das V, et al. Improvement in the prognosis 
of cirrhotic patients admitted to an intensive care unit, a retrospective 
study. Eur J Gastroenterol Hepatol. 2012;24:897–904.
 10. Sauneuf B, Champigneulle B, Soummer A, et al. Increased survival of cir-
rhotic patients with septic shock. Crit Care. 2013;17:R78.
 11. Theocharidou E, Pieri G, Mohammad AO, et al. The Royal Free Hospital 
score: a calibrated prognostic model for patients with cirrhosis admitted 
to intensive care unit. Comparison with current models and CLIF-SOFA 
score. Am J Gastroenterol. 2014;109:554–62.
 12. Thomson SJ, Moran C, Cowan ML, et al. Outcomes of critically ill patients 
with cirrhosis admitted to intensive care: an important perspective from 
the non-transplant setting. Aliment Pharmacol Ther. 2010;32:233–43.
 13. Rocco JR, Soares M. Outcome of patients with cirrhosis admitted to inten-
sive care. Rev Bras Ter Intensiva. 2010;22:11–8.
 14. Levesque E, Hoti E, Azoulay D, et al. Prospective evaluation of the prog-
nostic scores for cirrhotic patients admitted to an intensive care unit. J 
Hepatol. 2012;56:95–102.
 15. Das V, Boelle PY, Galbois A, et al. Cirrhotic patients in the medical 
intensive care unit: early prognosis and long-term survival. Crit Care Med. 
2010;38:2108–16.
 16. Frohlich S, Murphy N, Kong T, et al. Alcoholic liver disease in the intensive 
care unit: outcomes and predictors of prognosis. J Crit Care. 2014;29:1131.
e7–13.
 17. Gildea TR, Cook WC, Nelson DR, et al. Predictors of long-term mortality 
in patients with cirrhosis of the liver admitted to a medical ICU. Chest. 
2004;126:1598–603.
 18. Filloux B, Chagneau-Derrode C, Ragot S, et al. Short-term and long-term 
vital outcomes of cirrhotic patients admitted to an intensive care unit. Eur 
J Gastroenterol Hepatol. 2010;22:1474–80.
 19. Kavli M, Strom T, Carlsson M, Dahler-Eriksen B, Toft P. The outcome of criti-
cal illness in decompensated alcoholic liver cirrhosis. Acta Anaesthesiol 
Scand. 2012;56:987–94.
 20. Cholongitas E, Senzolo M, Patch D, et al. Risk factors, sequential organ 
failure assessment and model for end-stage liver disease scores for 
predicting short term mortality in cirrhotic patients admitted to intensive 
care unit. Aliment Pharmacol Ther. 2006;23:883–93.
 21. Levesque E, Saliba F, Ichai P, Samuel D. Outcome of patients with cirrhosis 
requiring mechanical ventilation in ICU. J Hepatol. 2014;60:570–8.
 22. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct 
syndrome that develops in patients with acute decompensation of cir-
rhosis. Gastroenterology. 2013;144:1426–37, 1437.e1–9.
 23. Burroughs A, Garcovich M, Vemala V, Davenport A, Shaw S, O’Beirne J. 
Admission serum lactate is a strong predictor of outcome in cirrhotics 
admitted to intensive care unit, and when added to the liver-specific 
scores of model for end-stage liver disease or UK model for end-stage 
liver disease, improves their respective predictive value. Gut. 2010;59:A13.
 24. Campbell J, McPeake J, Shaw M, et al. Validation of a prognostic scoring 
system for critically ill patients with cirrhosis admitted to ICU. Crit Care. 
2015;19:364.
 25. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transec-
tion of the oesophagus for bleeding oesophageal varices. Br J Surg. 
1973;60:646–9.
 26. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in 
patients with end-stage liver disease. Hepatology. 2001;33:464–70.
 27. Barber KM, Pioli SE, Blackwell JE, Collett D, Neuberger JM, Gimson AE. 
Development of a UK score for patients with end-stage liver disease. 
Hepatology. 2007;46:510A.
 28. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of 
disease classification system. Crit Care Med. 1985;13:818–29.
 29. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to 
assess the incidence of organ dysfunction/failure in intensive care units: 
results of a multicenter, prospective study. Working group on “sepsis-
related problems” of the European Society of Intensive Care Medicine. 
Crit Care Med. 1998;26:1793–800.
 30. Hanley JA, McNeil BJ. A method of comparing the areas under receiver 
operating characteristic curves derived from the same cases. Radiology. 
1983;148:839–43.
 31. Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Bur-
roughs AK. Systematic review: the model for end-stage liver disease—
should it replace Child–Pugh’s classification for assessing prognosis in 
cirrhosis? Aliment Pharmacol Ther. 2005;22:1079–89.
 32. Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality 
of life in the five years after intensive care: a cohort study. Crit Care. 
2010;14:R6.
